Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Report

Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 06, 2022
  • PAGES：214
  • REPORT CODE：GMM1350795
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • GE Healthcare

    • Agilent Technologies

    • Leica Biosystems Nussloch GmBH

    • Thermo Fisher Scientific Inc

    • F Hoffman La Roche

    • Qiagen NV

    • Pfizer

    • Foundation Medicine

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • PCR

    • In-situ Hybridization

    • Immunohistochemistry

    • Sequencing

    • Others

    Application:

    • Oncology

    • Neurological Disorders

    • Cardiovascular Disease

    • Immunological Disorders

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry Overview

      • 1.1.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Scope and Market Segments

      • 1.1.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry Characteristics

      • 1.1.3 Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 PCR

      • 1.2.2 In-situ Hybridization

      • 1.2.3 Immunohistochemistry

      • 1.2.4 Sequencing

      • 1.2.5 Others

    • 1.3 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Oncology

      • 1.3.2 Neurological Disorders

      • 1.3.3 Cardiovascular Disease

      • 1.3.4 Immunological Disorders

      • 1.3.5 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry PEST Analysis

    • 2.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry

    Chapter 3 Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market, by Manufacturer

    • 3.1 Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Top 3 Players

    Chapter 4 Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market, by Type (2017-2028)

    • 4.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Trend, by Type

    • 4.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Price Trend, by Type (2017-2028)

    • 4.3 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis

    • 7.1 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market, by Type

    • 7.2 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market, by Application

    • 7.3 North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis and Forecast, by Country

      • 7.3.1 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis

    • 8.1 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market, by Type

    • 8.2 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market, by Application

    • 8.3 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis

    • 9.1 APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market, by Type

    • 9.2 APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market, by Application

    • 9.3 APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis and Forecast, by Country

      • 9.3.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis

    • 10.1 Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market, by Type

    • 10.2 Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market, by Application

    • 10.3 Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Company Profiles

      • 11.1 GE Healthcare

        • 11.1.1 GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 GE Healthcare Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Profiles, Application and Specification

        • 11.1.3 GE Healthcare Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Agilent Technologies

        • 11.2.1 Agilent Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Agilent Technologies Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Profiles, Application and Specification

        • 11.2.3 Agilent Technologies Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Leica Biosystems Nussloch GmBH

        • 11.3.1 Leica Biosystems Nussloch GmBH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Profiles, Application and Specification

        • 11.3.3 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Thermo Fisher Scientific Inc

        • 11.4.1 Thermo Fisher Scientific Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Thermo Fisher Scientific Inc Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Profiles, Application and Specification

        • 11.4.3 Thermo Fisher Scientific Inc Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 F Hoffman La Roche

        • 11.5.1 F Hoffman La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 F Hoffman La Roche Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Profiles, Application and Specification

        • 11.5.3 F Hoffman La Roche Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Qiagen NV

        • 11.6.1 Qiagen NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Qiagen NV Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Profiles, Application and Specification

        • 11.6.3 Qiagen NV Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Pfizer

        • 11.7.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Pfizer Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Profiles, Application and Specification

        • 11.7.3 Pfizer Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Foundation Medicine

        • 11.8.1 Foundation Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Foundation Medicine Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Profiles, Application and Specification

        • 11.8.3 Foundation Medicine Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry Investment Prospect and Risk Assessment

    • 12.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production Value and Growth Rate (2017-2028)

    • Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production Value and Growth Rate (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate of PCR (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate of In-situ Hybridization (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate of Immunohistochemistry (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate of Sequencing (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate of Oncology (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate of Neurological Disorders (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate of Cardiovascular Disease (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate of Immunological Disorders (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share, by Manufacturer in 2021

    • Figure Global and China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share, by Manufacturer in 2022

    • Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Type (2017-2028)

    • Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Type (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Type (2017-2028)

    • Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value, by Type (2017-2028)

    • Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value Share, by Type (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Price Trend, by Type (2017-2028)

    • Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Type (2017-2028)

    • Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Type (2017-2028)

    • Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Type (2017-2028)

    • Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value, by Type (2017-2028)

    • Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value Share, by Type (2017-2028)

    • Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Price Trend, by Type (2017-2028)

    • Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Application (2017-2028)

    • Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Application (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Application (2017-2028)

    • Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value, by Application (2017-2028)

    • Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value Share, by Application (2017-2028)

    • Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value Share, by Application (2017-2028)

    • Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Application (2017-2028)

    • Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Application (2017-2028)

    • Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Application (2017-2028)

    • Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value, by Application (2017-2028)

    • Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value Share, by Application (2017-2028)

    • Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value Share, by Application (2017-2028)

    • Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Production, Import, Consumption and Export (2017-2022)

    • Table North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Type (2017-2028)

    • Table North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Type (2017-2028)

    • Figure North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Type (2017-2028)

    • Table North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Application (2017-2028)

    • Table North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Application (2017-2028)

    • Figure North America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Application (2017-2028)

    • Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Type (2017-2028)

    • Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Type (2017-2028)

    • Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Application (2017-2028)

    • Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure UK Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure France Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure France Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Table APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Type (2017-2028)

    • Table APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Type (2017-2028)

    • Table APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Application (2017-2028)

    • Table APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Application (2017-2028)

    • Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Value and Growth Rate (2017-2028)

    • Table GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GE Healthcare Product Profiles, Application and Specification

    • Table GE Healthcare Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Agilent Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Agilent Technologies Product Profiles, Application and Specification

    • Table Agilent Technologies Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Leica Biosystems Nussloch GmBH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Leica Biosystems Nussloch GmBH Product Profiles, Application and Specification

    • Table Leica Biosystems Nussloch GmBH Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Thermo Fisher Scientific Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Thermo Fisher Scientific Inc Product Profiles, Application and Specification

    • Table Thermo Fisher Scientific Inc Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffman La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffman La Roche Product Profiles, Application and Specification

    • Table F Hoffman La Roche Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Qiagen NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Qiagen NV Product Profiles, Application and Specification

    • Table Qiagen NV Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Foundation Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Foundation Medicine Product Profiles, Application and Specification

    • Table Foundation Medicine Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US